Lenalidomide results in a durable complete remission in acute myeloid leukemia accompanied by persistence of somatic mutations and a T-cell infiltrate in the bone marrow.

ABSTRACT:

SUBMITTER: Bansal D 

PROVIDER: S-EPMC6058793 | biostudies-literature | 2018 Jun

REPOSITORIES: biostudies-literature